Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Stanbio Acquires GDS Technology

By HospiMedica staff writers
Posted on 19 Sep 2001
Stanbio Laboratory (Boerne, TX, USA) has acquired GDS Technology (Elkhart, IN, USA), a manufacturer of clinical chemistry reagents, enzymes, and the Stat-Site multi-analyte point-of-care analyzer.

Stanbio manufactures clinical diagnostic reagents and products for serology, microbiology, and hematology. More...
The company's international distribution network is established in more than 70 countries around the world. The acquisition will further expand Stanbio's original equipment manufacturer (OEM) capabilities. Stanbio will also benefit from the research partnerships GDS has formed to explore its proprietary enzyme technology, which include the U.S. National Institutes of Health and the U.S. Department of Defense.

"With the addition of GDS Technology, we can strengthen our clinical chemistry line, which remains our core business, and further expand our product offering to include point-of-care testing,” said William R. Pippin, present of Stanbio Laboratory. "In addition, the unique synergy between our two operations will create numerous business opportunities as we merge the businesses.”




Related Links:
Stanbio
GDS Technology

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Automatic CLIA Analyzer
Shine i6000
New
Drug Testing Assays
Atellica DT 250 Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Adobe Stock

Blood Biomarkers Help Assess Growth Risks During Steroid Treatment in Duchenne Muscular Dystrophy

Children with Duchenne muscular dystrophy (DMD) commonly receive long-term corticosteroids to slow disease progression, but these drugs can impair linear growth and weaken bone. Understanding how specific... Read more

Molecular Diagnostics

view channel
Image: The Xpert Hemorrhagic Fever Panel test runs on Cepheid’s GeneXpert Dx systems (Photo courtesy of Cepheid)

WHO Emergency Listing Supports Rapid Molecular Testing for Ebola Outbreak Response

The Democratic Republic of the Congo is confronting an Ebola Bundibugyo outbreak that the World Health Organization (WHO) designated a Public Health Emergency of International Concern on May 17, 2026.... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification

Colorectal cancer remains a leading cause of cancer mortality, and current noninvasive screening methods still miss many precancerous lesions. Clinicians therefore need tools that improve risk stratification... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.